Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Discover which stablecoins pay interest safely and how to assess counterparty risk. This guide helps you compare options and reduce exposure while earning yields.
24,010 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
When a celebrity unveils a dramatic look, it often ripples into everyday spending. This article explores kardashian d...
Both ServiceNow and Salesforce fell roughly 5% on the latest trading session as AI licensing concerns rattled investo...
Star Group's Q2 2026 results shed light on the company's path to profitability and growth. This article breaks down t...
A Chicago federal jury has ordered Boeing to pay $49.5 million to Samya Stumo's family, ending a high-profile liabili...
QYLD offers a headline 12% yield through its covered-call strategy, yet 10-year total returns lag the Nasdaq-100 and ...
A large institutional bet on Futu stock sparked headlines as shares fell nearly a quarter. This article breaks down w...
SpaceX may be heading for a high-profile IPO, and the market is watching closely. This guide explains what could chan...
Oil sits near $90 per barrel on June 12, 2026, with Brent guiding the market. Traders weigh supply discipline, demand...
Investors are buzzing about QuantumScape after news of a major automaker collaboration. This article breaks down what...
As Warren Buffett steps back, Berkshire Hathaway's portfolio is evolving. This guide breaks down how the post-Buffett...
A new, secretive cargo delivery concept tested by SpaceX could reshape global logistics. This investor-focused overvi...